AAVANTIBIO

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark AAVANTIBIO was filed as Word mark on 07/05/2022 at the World Intellectual Property Organization.

Trademark Details Last update: June 23, 2023

Trademark form Word mark
File reference 1677776
Countries Canada Switzerland European Community United Kingdom Norway
Base trademark US No. 97203384, January 5, 2022
Application date July 5, 2022
Expiration date July 5, 2032

Trademark owner

18th Floor
245 First Street
US

Trademark representatives

Pierce Atwood LLP, 254 Commercial Street US

goods and services

05 Biological treatments, namely, biological preparations for use in the clinical, medicinal, and therapeutic treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases; biopharmaceutical reagents for medical use, for use in gene therapy for the treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases; biopharmaceutical preparations for human use for the treatment of Friedreich's Ataxia, genetic disorders, genetic diseases, and rare diseases

Trademark history

Date Document number Area Entry
June 21, 2023 2023/25 Gaz CH Rejection
March 15, 2023 2023/11 Gaz NO Rejection
January 4, 2023 2023/1 Gaz EM Rejection
November 9, 2022 2022/45 Gaz GB Rejection
July 5, 2022 2022/30 Gaz US Registration

ID: 141677776